Cardio Diagnostics Hldgs Inc (CDIO) Stock Price, Quote & News

Company Profile

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform that offers new epigenetic and genetic insights...

Industry: Biotechnology

Sector: Healthcare

Phone: 855 226 9991

Website: cdio.ai

Address:

311 West Superior Street, Suite 444, Chicago, United States

Napoliblue Aug. 29 at 5:49 PM

$CDIO drop some news anything like $IPDN did today going from $2.79 to $10.84 today take advantage of the low float . We are trading at $.12? pre-reverse this is pathetic

1 · Reply

Redsox1975 Aug. 29 at 12:27 PM

$CDIO in annual report meesha says she believes her test is the best on the market. never sold a test and a 1-30 reverse split, $900 in revenues a quarter says other wise. one filthy indian fraud

0 · Reply

Quarca Aug. 27 at 8:49 PM

$CDIO Both the Epi+Gen CHD™ and PrecisionCHD™ clinical blood tests currently are offered as LDTs through an experienced laboratory with the appropriate Clinical Laboratory Improvement Amendments of 1988 (“CLIA”) certification and state licensure. However, we are currently setting up an internal operational hub that includes a CLIA laboratory. We anticipate completing this process in 2025. However, we are moving at a measured pace in order to preserve resources, so the timing of completion of the internal CLIA laboratory could be delayed. We will continue to use the services of our outside laboratory without interruption until our laboratory is operational.

1 · Reply

85mph Aug. 27 at 2:40 PM

$CDIO dead..

0 · Reply

kemsma62 Aug. 26 at 7:52 PM

$CDIO 🤞🍀💥 In this clip from the Lab Rats to Unicorns podcast, Dr. Meesha Dogan, PhD, our CEO & Co-Founder, explains #epigenetics in simple terms with the example of how smoking leaves measurable marks on our DNA. It was Meesha’s groundbreaking work in epigenetics, shaped by her extensive academic background and personal drive to end the burden of heart disease considering her own family history, that led to the creation of Cardio Diagnostics’ solutions. Today, epigenetic testing remains at the very core of how we assess heart attack risk and detect the presence of coronary heart disease with precision. Watch the full conversation here: https://lnkd.in/e_HE4qK9 https://www.linkedin.com/posts/cardio-diagnostics-inc_epigenetics-podcast-precisioncardiovascularmedicine-activity-7366113784622497794-ip2y?utm_medium=ios_app&rcm=ACoAAAUQoJYBpYlpkzTIKG_EB77BBoq8W1BP448&utm_source=social_share_send&utm_campaign=copy_link

2 · Reply

Redsox1975 Aug. 26 at 5:30 PM

$CDIO In this clip from the Lab Rats to Unicorns podcast, Dr. Meesha Dogan, our CEO & Co-Founder, explains #epigenetics in simple terms with the example of how smoking leaves measurable marks on our DNA. It was Meesha’s groundbreaking work in epigenetics, shaped by her extensive academic background and personal drive to end the burden of heart disease considering her own family history, that led to the creation of Cardio Diagnostics’ solutions. Today, epigenetic testing remains at the very core of how we assess heart attack risk and detect the presence of coronary heart disease with precision. Watch the full conversation here: https://www.youtube.com/watch?v= meesha is a feckin dirty rat #podcast #PrecisionCardiovascularMedicine

0 · Reply

Redsox1975 Aug. 26 at 12:09 PM

$CDIO 1 share traded for this feckin rubbish. Scam

0 · Reply

Redsox1975 Aug. 25 at 4:31 PM

$CDIO This scam company is a dusgrace bankruptcy soon 30,000 in tevenues since its ipo ceo from india gets 1.3 mil a year

0 · Reply

BlackHoleFund Aug. 23 at 8:43 AM

$CDIO Cardio Diagnostics Holdings Inc is a medical technology company with early stage adoption

1 · Reply

ekaj15 Aug. 23 at 7:26 AM

$CDIO the old crew. Had so much hope for this one. 😢 all that glitters is not gold.

0 · Reply

Cardio Diagnostics Receives Gapfill Payment Rates for AI-Driven Cardiovascular Tests from the Centers for Medicare and Medicaid Services (CMS)

Jul 8, 2025, 8:31 AM EDT - 7 weeks ago

Cardio Diagnostics Enters Into an Agreement with AGEPHA Pharma to Advance Precision Assessment and Management of Inflammation Associated with Coronary Heart Disease

Jun 10, 2025, 8:35 AM EDT - 2 months ago

Cardio Diagnostics Secures Japanese Patent for AI-Driven Cardiovascular Disease Detection Technology

May 29, 2025, 8:35 AM EDT - 3 months ago

Cardio Diagnostics Holdings, Inc. Regains Compliance with Nasdaq Minimum Bid Price

May 20, 2025, 8:35 AM EDT - 3 months ago

Cardio Diagnostics Broadens Access to Precision Cardiovascular Care with New Practice Partnerships Across U.S. Mainland and Puerto Rico

May 8, 2025, 8:35 AM EDT - 4 months ago

Cardio Diagnostics Holdings, Inc. Announces 1-for-30 Reverse Stock Split

Mar 26, 2025, 8:31 AM EDT - 5 months ago

Cardio Diagnostics Holdings, Inc. to Showcase Enhanced PrecisionCHD™, Actionable Clinical Intelligence™ and New Clinical Advancements at the American College of Cardiology's 74th Annual Scientific Session

Feb 4, 2025, 8:31 AM EST - 7 months ago

Cardio Diagnostics Expands the Reach of its AI-Driven Precision Cardiovascular Medicine Tests by Partnering with Seven New Provider Organizations

Dec 16, 2024, 8:31 AM EST - 9 months ago

Cardio Diagnostics Holdings, Inc. Receives Final Medicare Pricing Determination from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests

Nov 12, 2024, 8:31 AM EST - 10 months ago

Cardio Diagnostics Holdings, Inc. to Sponsor and Showcase AI-Powered Solutions at the FLAACOs Annual Conference

Oct 1, 2024, 8:31 AM EDT - 11 months ago

Cardio Diagnostics Holdings, Inc. Receives Preliminary Medicare Pricing from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests

Jul 29, 2024, 8:45 AM EDT - 1 year ago

Cardio Diagnostics Holdings Inc. Launches CDIO.AI, A Redesigned Website Enhancing User Experience and Highlighting Our AI-Driven Cardiovascular Solutions

Jun 27, 2024, 8:31 AM EDT - 1 year ago

Cardio Diagnostics Announces Its Epi+Gen CHD Heart Attack Risk Assessment Test is Now Available at Meijer Supercenter in McHenry, Illinois

Jun 25, 2024, 8:31 AM EDT - 1 year ago

Cardio Diagnostics Announces It's Exhibiting at the 2024 Onsite Employee Health Clinics Forum

Jun 10, 2024, 8:31 AM EDT - 1 year ago

Cardio Diagnostics Holdings, Inc. Achieves SOC 2 Type I Compliance Certification for Security and Confidentiality

May 21, 2024, 8:31 AM EDT - 1 year ago

Cardio Diagnostics to Participate in the Centers for Medicare and Medicaid Services' (CMS) Clinical Laboratory Fee Schedule (CLFS) Annual Meeting to Secure Medicare Payment for Its Innovative Tests

May 13, 2024, 8:31 AM EDT - 1 year ago

Cardio Diagnostics Holdings, Inc. Announces the Availability of Its Clinical Tests at Family Medicine Specialists' Retail Healthcare Clinic at Walmart Supercenter in Round Lake Beach, Illinois, That Offers Walk-In Appointments Seven Days a Week

Apr 29, 2024, 8:31 AM EDT - 1 year ago

Cardio Diagnostics Announces Publication of Study Showing That its PrecisionCHD™ Test Could Save Health Insurers Over $113 Million Annually

Apr 9, 2024, 8:31 AM EDT - 1 year ago

Exponential Health Partners with Cardio Diagnostics to Elevate Cardiovascular Disease Prevention in Michigan

Apr 4, 2024, 8:31 AM EDT - 1 year ago

Cardio Diagnostics Holdings, Inc. Enters Into a Nationwide Telehealth Agreement with Navierre

Mar 14, 2024, 8:31 AM EDT - 1 year ago

Cardio Diagnostics Holdings, Inc. to Showcase HeartRisk and Actionable Clinical Intelligence Version 3 at the American College of Cardiology's 73rd Annual Scientific Session

Mar 5, 2024, 8:31 AM EST - 1 year ago

Cardio Diagnostics Holdings, Inc. Announces Issuance of Second U.S. Patent for Compositions and Methods for Detecting Predisposition to Cardiovascular Disease

Feb 15, 2024, 8:46 AM EST - 1 year ago

Cardio Diagnostics Holdings, Inc. Expands HeartRisk™ Platform Offering to Diverse Markets in Conjunction with Nationwide Rollout

Feb 7, 2024, 8:31 AM EST - 1 year ago

Cardio Diagnostics Holdings, Inc. Expands Partnership with Family Medicine Specialists to Bring Its Specialty Cardiology Tests to Select Walmart Supercenters

Feb 5, 2024, 8:31 AM EST - 1 year ago

Houston-Based resTOR Longevity Clinic to Offer Cardio Diagnostics' AI-Driven Epigenetic-Genetic Heart Disease Tests

Jan 24, 2024, 8:31 AM EST - 1 year ago

Cardio Diagnostics Holdings, Inc. Accelerates Cardiac Care Innovation with Appointment of Dr. Vimal Ramjee as Strategic Advisor

Jan 8, 2024, 8:31 AM EST - 1 year ago

Cardio Diagnostics Holdings, Inc. Announces the Grant of a Patent in India

Jan 4, 2024, 11:36 AM EST - 1 year ago

CORRECTING and REPLACING Cardio Diagnostics Holdings, Inc. Unveils Groundbreaking Employer Cardiovascular Disease Risk Intelligence Platform, HeartRisk™

Jan 4, 2024, 8:31 AM EST - 1 year ago

Cardio Diagnostics Holdings, Inc. Unveils Groundbreaking Employer Cardiovascular Disease Risk Intelligence Platform, HeartRisk™

Jan 3, 2024, 8:31 AM EST - 1 year ago

American Medical Association (AMA) Grants Cardio Diagnostics a Dedicated CPT PLA Reimbursement Code for Epi+Gen CHD, an AI-powered Test for Assessing the Probability of a Heart Attack or Coronary Heart Disease Event

Jan 2, 2024, 8:31 AM EST - 1 year ago

American Medical Association (AMA) Grants Cardio Diagnostics Holdings, Inc.'s AI-Powered Coronary Heart Disease Detection Test, PrecisionCHD, a Dedicated CPT PLA Reimbursement Code

Dec 21, 2023, 9:21 AM EST - 1 year ago

Cardio Diagnostics Holdings, Inc. Appoints Biotechnology Investor, Executive & Serial Entrepreneur Paul Burton to its Board of Directors

Dec 6, 2023, 8:31 AM EST - 1 year ago

Cardio Diagnostics Holdings, Inc. Regains Nasdaq Minimum Bid Price Requirement

Dec 4, 2023, 5:38 PM EST - 1 year ago

CORRECTING and REPLACING Cardio Diagnostics Holdings, Inc. Convenes Cardiovascular Care & Risk Roundtable at the 42nd Annual J.P. Morgan Healthcare Conference

Dec 4, 2023, 8:31 AM EST - 1 year ago

Cardio Diagnostics Holdings, Inc's Convenes Cardiovascular Care & Risk Roundtable at the 42nd Annual J.P. Morgan Healthcare Conference

Nov 28, 2023, 8:31 AM EST - 1 year ago

American Medical Association is Reviewing Cardio Diagnostics Holdings, Inc's Integrated Epigenetic-Genetic Cardiovascular Medicine Tests for CPT PLA Codes

Nov 20, 2023, 8:31 AM EST - 1 year ago

Cardio Diagnostics Holdings, Inc. Announces Breakthrough in Coronary Heart Disease Detection with PrecisionCHD Test, Published in the Journal of the American Heart Association

Nov 7, 2023, 9:01 AM EST - 1 year ago

Family Medicine Specialists Selects Cardio Diagnostics' Epigenetic-Genetic Tests for Assessing Heart Attack Risk for its BlueCross BlueShield Patients

Oct 31, 2023, 9:01 AM EDT - 1 year ago

Cardio Diagnostics Holdings, Inc Receives Innovative Technology Contract from Vizient for Its Novel AI-Driven Precision Heart Disease Tests – Epi+Gen CHD & PrecisionCHD

Oct 17, 2023, 9:01 AM EDT - 2 years ago

Cardio Diagnostics Holdings, Inc and Aimil Ltd Join Forces to Introduce Cardiovascular Epigenetic Technologies to India

Oct 12, 2023, 8:30 AM EDT - 2 years ago

Cardio Diagnostics Holdings, Inc Launches New Lab and Fulfillment Center, Paving Way for Expanded Testing Capacity, Reduced Costs, Reduced Turnaround Time and Improved Margins

Sep 20, 2023, 9:01 AM EDT - 2 years ago

Cardio Diagnostics Publishes Novel and Scalable Pathways to Enhance Global Coronary Heart Disease Care through Precision Epigenetics in Epigenomics

Sep 7, 2023, 9:01 AM EDT - 2 years ago

Cardio Diagnostics Holdings, Inc. and Truckers Health Network Enter Into a Strategic Collaboration to Accelerate Cardiovascular Health Initiatives in the Trucking Industry

Sep 6, 2023, 9:16 AM EDT - 2 years ago

Cardio Diagnostics Holdings, Inc Partners with Ascension Borgess Hospital's Heart Attack Prevention Clinic on Coronary Artery Disease Study

Sep 5, 2023, 9:01 AM EDT - 2 years ago

Cardio Diagnostics Holdings, Inc to Participate in Upcoming Investor Conferences

Aug 18, 2023, 8:30 AM EDT - 2 years ago

Cardio Diagnostics Partners With FRSTeam of East Kansas and West Missouri to Host First Onsite Heart Disease Fair in Kansas Using Epigenetic-Genetic Technologies

GENE

Aug 2, 2023, 8:30 AM EDT - 2 years ago

Cardio Diagnostics Holdings, Inc Announces Expansion of IP Portfolio in Australia with Notice of Allowance of Patent Application

Jul 6, 2023, 9:05 AM EDT - 2 years ago

Cardio Diagnostics Holdings, Inc and RiverRock Medical Partner to Bring Epigenetic-Genetic Heart Disease Testing to Austin, Texas

Jun 21, 2023, 8:45 AM EDT - 2 years ago

Cardio Diagnostics Holdings, Inc Democratizes CHD Detection with Nationwide Launch of PrecisionCHD™

Jun 13, 2023, 9:01 AM EDT - 2 years ago

Cardio Diagnostics Publishes Research Highlighting the Reversibility of Epigenetic Signatures of Coronary Heart Disease

Napoliblue Aug. 29 at 5:49 PM

$CDIO drop some news anything like $IPDN did today going from $2.79 to $10.84 today take advantage of the low float . We are trading at $.12? pre-reverse this is pathetic

1 · Reply

Redsox1975 Aug. 29 at 12:27 PM

$CDIO in annual report meesha says she believes her test is the best on the market. never sold a test and a 1-30 reverse split, $900 in revenues a quarter says other wise. one filthy indian fraud

0 · Reply

Quarca Aug. 27 at 8:49 PM

1 · Reply

85mph Aug. 27 at 2:40 PM

$CDIO dead..

0 · Reply

kemsma62 Aug. 26 at 7:52 PM

2 · Reply

Redsox1975 Aug. 26 at 5:30 PM

0 · Reply

Redsox1975 Aug. 26 at 12:09 PM

$CDIO 1 share traded for this feckin rubbish. Scam

0 · Reply

Redsox1975 Aug. 25 at 4:31 PM

$CDIO This scam company is a dusgrace bankruptcy soon 30,000 in tevenues since its ipo ceo from india gets 1.3 mil a year

0 · Reply

BlackHoleFund Aug. 23 at 8:43 AM

$CDIO Cardio Diagnostics Holdings Inc is a medical technology company with early stage adoption

1 · Reply

ekaj15 Aug. 23 at 7:26 AM

$CDIO the old crew. Had so much hope for this one. 😢 all that glitters is not gold.

0 · Reply

Redsox1975 Aug. 22 at 3:05 PM

$CDIO next stop 12-15

0 · Reply

Coupedayville Aug. 21 at 3:22 PM

$CDIO

0 · Reply

kemsma62 Aug. 21 at 1:55 PM

$CDIO 🍀🤞💥 How can self-funded employers tackle one of the biggest cost drivers in healthcare? In a white paper authored by Meesha Dogan, PhD, CEO and Co-Founder of Cardio Diagnostics, discover how Direct-to-Employer cardiovascular health programs can help lower costs, boost productivity, and improve employee heart health. With cardiovascular disease projected to affect 61% of U.S. adults by 2050, and cost over $1 trillion annually, the time to act is now. Read the full white paper to explore actionable strategies for employers and healthcare providers: https://lnkd.in/eKyY6yi4 #CardioDiagnostics #WorkforceHealth #HeartHealth #DirectToEmployer #CVDPrevention #PrecisionCardiovascularMedicine https://www.linkedin.com/posts/cardio-diagnostics-inc_navigating-the-future-of-direct-to-employer-activity-7364290064308150276-kt40?utm_medium=ios_app&rcm=ACoAAAUQoJYBpYlpkzTIKG_EB77BBoq8W1BP448&utm_source=social_share_send&utm_campaign=copy_link

0 · Reply

longjohntrader Aug. 21 at 1:54 PM

$ISPC $AEMD $CDIO APM medical device - test on Fire today

1 · Reply

BigSqueezeComing Aug. 21 at 12:57 PM

$CDIO pm gappers…

0 · Reply

Redsox1975 Aug. 21 at 12:51 PM

$CDIO up .35 no chance hilarious

0 · Reply

Redsox1975 Aug. 21 at 12:51 PM

$CDIO can we drop below $3 today lets go meesha you POS fraud

0 · Reply

Redsox1975 Aug. 21 at 9:18 AM

$CDIO insiders own very little shares directly

1 · Reply

Redsox1975 Aug. 20 at 9:27 PM

$CDIO 17 unnamed mom snd pop clinics, walmart and meijer super store and still no tests done for cardio heart test. fraud scam company folks 300 mil of investor money lost since ipo

0 · Reply

Redsox1975 Aug. 20 at 3:26 PM

$CDIO this scam will file bankruptcy on christmas eve on a facebook post meesha is a douche

0 · Reply

Redsox1975 Aug. 20 at 3:05 PM

$CDIO bankruptcy soon 8000 in revenues for this scam ceo makes 1.3 mil a yr classic fraud

0 · Reply

Redsox1975 Aug. 20 at 2:49 PM

$CDIO short this to 0 easy money

0 · Reply

Market Cap	6.72M
Revenue (ttm)	30,000.00
Net Income (ttm)	-8.38M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-27,933.33%
Debt to Equity Ratio	0.00

Volume	6,800
Avg Vol	37,146
Day's Range	N/A - N/A
Shares Out	1.76M
Stochastic %K	92%
Beta	2.96
Analysts	Sell
Price Target	$5.00